MedTrace Logo

The Efficacy Of Elonide Nasal Corticosteroids In Managing Allergic Rhinitis

NCT05912192 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 163

Last updated 2023-06-22

No results posted yet for this study

Summary

The aim of this clinical study is to compare the efficacy of Elonide Nasal Spray to Nasonex Nasal Spray and Placebo (non-active ingredient) in the management of allergic rhinitis.

There are two hypotheses of this study:

1. Elonide nasal spray is same efficacy to Nasonex nasal spray.
2. Elonide nasal spray is more efficient to placebo.

Conditions

  • Allergic Rhinitis

Interventions

DRUG

Elonide Nasal Spray

50mcg/dose One puff for each nostrils twice daily

DRUG

Nasonex Nasal Spray

50mcg/dose One puff for each nostrils twice daily

DRUG

Normal saline

50mcg/dose of 0.9% sodium chloride One puff for each nostrils twice daily

Sponsors & Collaborators

  • HOE pharmaceuticals Sdn. Bhd.

    collaborator UNKNOWN

  • National University of Malaysia

    lead OTHER

Principal Investigators

  • Hardip Singh Gendeh · Department of Otorhinolaryngology, Faculty of Medicine, Universiti Kebangsaan Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-24
Primary Completion
2023-04-14
Completion
2023-04-14

Countries

  • Malaysia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05912192 on ClinicalTrials.gov